Is Capecitabine Efficacious in Triple Negative Metastatic Breast Cancer?

Publisher： Karger

E-ISSN： 1423-0232|79|5-6|331-336

ISSN： 0030-2414

Source： Oncology, Vol.79, Iss.5-6, 2011-03, pp. : 331-336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine – Case Report

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Triple-negative breast cancer

By Bartsch Rupert  

Wiener Medizinische Wochenschrift, Vol. 160, Iss. 7-8, 2010-04 ,pp. : 174-181

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine for the oral treatment of metastatic breast cancer

By Cortés-Funes Hernán  

Women's Health, Vol. 2, Iss. 6, 2006-11 ,pp. : 805-817

Future Medicine

Access to resources Recommend Favorite

Topic: Capecitabine (Xeloda) for metastatic breast cancer

By  

Journal of Clinical Excellence, Vol. 4, Iss. 4, 2002-09 ,pp. : 425-428

Radcliffe Press

Access to resources Recommend Favorite

Triple Negative Breast Cancer: A Review

By  

Current Women's Health Reviews, Vol. 5, Iss. 3, 2009-01 ,pp. : 149-156

Bentham Science Publishers

Access to resources Recommend Favorite